Genetic Mortality Risk Can Be Attenuated by Lifestyle

Share this content:
Genetic Mortality Risk Can Be Attenuated by Lifestyle
Genetic Mortality Risk Can Be Attenuated by Lifestyle

TUESDAY, Nov. 8, 2016 (HealthDay News) -- Genetic variations correlate with mortality in the elderly, although their effect can be influenced by lifestyle behaviors, according to a study published online Nov. 2 in the Journal of the American Geriatrics Society.

Debora Rizzuto, Ph.D., from the Karolinska Institutet and Stockholm University, and colleagues conducted a 25-year population-based cohort study involving 1,229 individuals aged 75 years and older. The authors examined the correlations between single nucleotide variations in 14 genes, relevant lifestyle risk behaviors, and mortality.

The researchers found that the likelihood of dying was increased for individuals with allelic variation in four genes related to cardiovascular disease and metabolism (apolipoprotein [APO]C1 GG and AG carriers, APOE ε4 carriers, insulin-degrading enzyme [IDE] TC carriers, and phosphatidylinositol 3-kinase [PI3KCB] GG carriers). Compared to those with no adverse alleles, individuals with multiple adverse alleles had a 62 percent higher mortality rate. The mortality rate was 65 percent lower for people with no risk behaviors (low-risk profile) than for those with all risk behaviors (high-risk profile). Independent of genetic risk profile, mortality was up to 64 percent lower for individuals with a low-risk profile versus those with a moderate high- or high-risk profile and at least one genetic risk factor.

"In conclusion, this study extends past observations that genetic background is related to survival, but lifestyle behaviors attenuated the genetic risk, suggesting that that a long life can be achieved even in the presence of unfavorable genes," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »